Stock Events

Stock Events

Altamira Therapeutics 

$0.073900
57
+$0.00+4.08% 19:49 Today

Statistics

Day High
0.071
Day Low
0.063
52W High
0.148
52W Low
0.05
Volume
10,100
Avg. Volume
4,079
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

9SepExpected
Q4 0
Q2 2024
Q1 2025
Q2 2025
Q4 2025
Next
-2.38
-1.77
-1.15
-0.54
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-8.46MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap138.42B
Vertex Pharmaceuticals is a competitor because it also focuses on developing treatments for serious genetic diseases, potentially overlapping with Altamira's therapeutic areas.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences competes in the biopharmaceutical space, developing drugs that could be in direct competition with Altamira's offerings for various diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.22B
Regeneron Pharmaceuticals is known for its innovation in biotechnology, potentially competing with Altamira in developing therapies for similar conditions.
AMGEN
AMGN
Mkt Cap236.38B
Amgen is a biotech giant that develops novel therapies for serious illnesses, which could directly compete with Altamira's product pipeline.
Biogen
BIIB
Mkt Cap32.63B
Biogen focuses on developing therapies for neurological diseases, a space where Altamira could also be making strides, making them competitors.
Alnylam Pharmaceuticals
ALNY
Mkt Cap35.61B
Alnylam Pharmaceuticals works on RNAi therapeutics, a cutting-edge area of medicine that could overlap with Altamira's research interests.
Ionis Pharmaceuticals
IONS
Mkt Cap9.65B
Ionis Pharmaceuticals is a leader in RNA-targeted drug discovery and development, potentially competing with Altamira in genetic disease treatments.
CRISPR Therapeutics
CRSP
Mkt Cap5.39B
CRISPR Therapeutics is at the forefront of gene editing, a technology that could be used to develop treatments in the same domains as Altamira.

About

ALTAMIRA THERAPEUTICS LTD
Show more...
CEO
Dr. Thomas Meyer Ph.D.
Country
Bermuda
ISIN
BMG0360L1349

Listings

OTC Link
US
CYTOF

0 Comments

Share your thoughts

FAQ

What is Altamira Therapeutics stock price today?▼
The current price of CYTOF is $0.07 USD — it has increased by +4.08% in the past 24 hours. Watch Altamira Therapeutics stock price performance more closely on the chart.
What is Altamira Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Altamira Therapeutics stocks are traded under the ticker CYTOF.
Is Altamira Therapeutics stock price growing?▼
CYTOF stock has risen by +4.08% compared to the previous week, the month change is a +17.3% rise, over the last year Altamira Therapeutics has showed a +44.9% increase.
When is the next Altamira Therapeutics earnings date?▼
Altamira Therapeutics is going to release the next earnings report on September 09, 2026.
What is Altamira Therapeutics revenue for the last year?▼
Altamira Therapeutics revenue for the last year amounts to 0 USD.
What is Altamira Therapeutics net income for the last year?▼
CYTOF net income for the last year is -8.46M USD.
In which sector is Altamira Therapeutics located?▼
Altamira Therapeutics operates in the Other sector.
When did Altamira Therapeutics complete a stock split?▼
Altamira Therapeutics has not had any recent stock splits.
Where is Altamira Therapeutics headquartered?▼
Altamira Therapeutics is headquartered in Hamilton, Bermuda.